The different effects of i.c.v. injection of pituitary adenylate cyclase activating polypeptide (PACAP) on prolactin secretion in adult male and lactating rats

Experimental Animals

Volumn 58, Issue 5, 2009, Pages 489-495

  Tohei, Atsushi ^a   Ikeda, Masashi ^a   Hokao, Ryoji ^b   Shinoda, Motoo ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b Institute for Animal Reproduction   (Japan)

Author keywords

Dopamine; PACAP; PRL

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PROLACTIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; FEMALE; HYPOTHALAMUS; LACTATION; MALE; MEDIAN EMINENCE; NONHUMAN; PROLACTIN RELEASE; RAT;

ANIMALS; ANIMALS, SUCKLING; DOPAMINE; FEMALE; INJECTIONS, INTRAVENTRICULAR; MALE; MEDIAN EMINENCE; NEURONS; NEUROTRANSMITTER AGENTS; PEPTIDE FRAGMENTS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROLACTIN; RATS; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; RATTUS;

EID: 73249118253     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.58.489     Document Type: Article

References (19)

1. Arbogast, L.A. and Voogt, J.L. 1991. Hyperprolactinemia increases and hypoprolactinemia decreases tyrosine hydroxylase messenger ribonucleic acid levels in the arcuate nuclei, but not the substantia nigra or zona incerta. Endocrinology 128: 997-1005.
2. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
3. Dow, R.C., Bennie, J., and Fink, G. 1994. Pituitary adenylate cyclase-activating peptide-38 (PACAP-38) is release into hypophysial portal blood in the normal male, female rat. J. Endocrinol. 142: R1-R4.
4. Grinevich, V., Fournier, A., and Pelletier, G. 1997. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus. Brain. Res. 773: 190-196.
5. Hannibal, J., Mikkelsen, J.D., Clausen, H., Holst, J.J., Wulff, B.S., and Fahrenkrug, J. 1995. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul. Pept. 55: 133-148.
6. Huang, S.K. and Pan, J.T. 1996. Stimulatory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide on tuberoinfundibular dopaminergic neuron activity in estrogen-treated ovariectomized rats and their correlation with prolactin secretion. Neuroendocrinology 64: 208-214.
7. Masuo, Y., Ohtaki, T., Masuda, Y., Nagai, Y., Suno, M., Tsuda, M., and Fujino, M. 1991. Autoradiographic distribution of pituitary adenylate cyclase activating polypeptide (PACAP) binding sites in the rat brain. Neurosci. Lett. 126: 103-106.
8. Masuo, Y., Ohtaki, T., Masuda, Y., Tsuda, M., and Fujino, M. 1992. Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain section. Brain. Res. 575: 113-123.
9. Miyata, A., Arimura, A., Dahl, D.H., Minamino, N., Uehara, A., Jiang, L., Culler, M.D., and Coy, D.H. 1989. Isolation of a novel 38 residue-hypothalamic peptide which stimulates adenylate cyclase in pituitary cell. Biochem. Biophys. Res. Commun. 164: 567-574.
10. Miyata, A., Jiang, L., Dahl, R.D., Kitada, C., Kubo, K., Fujino, M., Minamino, N., and Arimura, A. 1990. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem. Biophys. Res. Commun. 170: 643-648.
11. Moro, O. and Lernet, E.A. 1997. Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type1 receptor agonist. J. Biol. Chem. 272: 966-970.
12. Rawlings, S.R. and Hezareh, M. 1996. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Endocrinol. Rev. 17: 4-29.
13. Robberecht, P., Gourlet, P., De Neef, P., Woussen-Colle, M.C., Vandermeers-Piret, M.C., Vandermeers, A., and Christophe, J. 1992. Structural requirements for the occupany of pituitary adenylate-cyclase-activating peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Eur. J. Biochem. 207: 239-246.
14. Shioda, S., Shuto, Y., Somogyvari-Vigh, A., Legradi, G., Onda, H., Coy, D.H., Nakajo, S., and Arimura, A. 1997. Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain. Neurosci. Res. 28: 345-354.
15. Tohei, A., VandeGarde, B., Arbogast, L.A., and Voogt, J.L. 2000. Calcitonin inhibition of prolactin secretion in lactating rats: mechanism of action. Neuroendocrinology 71: 327-332.
16. Tohei, A., Matsuzaki, M., and Kogo, H. 2001. Antagonist of pituitary adenylate cyclase activating polypeptide suppresses prolactin secretion without changing the activity of dopamine neurons in lactating rats. Neuroendocrinology 73: 68-74.
17. Vandermeers, A., Vandenborre, S., Hou, X., De Neef, P., Robberecht, P., Vandermeers-Piret, M.C., and Christophe, J. 1992. Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes. Eur. J. Biochem. 208: 815-819.
18. Viau, V., Montagne, M.N., Sarrieau, A., Meaney, M.J., and Rostene, W. 1992. Changes in vasoactive intestinal peptide binding site densities in the female rat central nervous system and pituitary during lactation. J. Neuroendcrinol. 4: 759-764.
19. Yamauchi, K., Murakami, Y., Nishiki, M., Tanaka, J., Koshimura, K., and Kato, Y. 1995. Possible involvement of vasoactive intestinal polypeptide in the central stimulation of pituitary adenylate cyclase-activating polypeptide on prolactin secretion in the rat. Neurosci. Lett. 189: 131-134.